|Mr. Jay T. Flatley||Chairman & Acting CEO||N/A||N/A||1953|
|Mr. Zachariah Serber Ph.D.||Co-Founder, Chief Science Officer & Director||N/A||N/A||1975|
|Mr. Aaron Kimball||Chief Technology Officer||453.83k||N/A||1984|
|Ms. Mina Kim||Chief Legal Officer||641.09k||N/A||1974|
|Ms. Enakshi Singh||Chief Financial Officer||N/A||N/A||1978|
|Mike Dulin||Director of Communications||N/A||N/A||N/A|
|Ms. Judy Gilbert||Chief People Officer||N/A||N/A||N/A|
|Ms. Aindrea Campbell||Chief Manufacturing Officer||N/A||N/A||N/A|
|Mr. Lincoln Germain||Chief Commercial Officer||N/A||N/A||N/A|
|Mr. Subodh S. Deshmukh||Chief Devel. Officer||N/A||N/A||N/A|
Zymergen Inc. designs, engineers, and optimizes microbes for industrial applications in United States, Asia, and Europe. The company has a platform that treats the genome as a search space, to identify genetic changes that improve the economics for its customers' bio-based products for a range of industries, including chemicals and materials, agriculture, and pharmaceuticals. Zymergen's platform is used to discover novel molecules used to enable unique material properties. The company was incorporated in 2013 and is based in Emeryville, California.
Zymergen Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.